EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY 4.0

On the potential value of eHTA: a commentary on “Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique”

Nick Dragojlovic iD, Mark Harrison, Larry David Lynd

International Journal of Technology Assessment in Health Care · 2025

DOI: 10.1017/s0266462325100202 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift International Journal of Technology Assessment in Health Care, 2025. Verfasst von Nick Dragojlovic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, https://ror.org/03rmrcq20University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Delphi Technique, Consensus. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NanoMedicines Innovation Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The HTAi Health Technology Assessment (eHTA) Working Group’s (WG) development of a consensus definition of early eHTA, as reported in Grutters et al. (1), represents a major step towards the establishment of eHTA as a distinct subdiscipline of HTA. In a global landscape in which growth in pharmaceutical spending is driven by the increasing number of high-cost specialty drugs (2–6), and where the cost of new entrants is not systematically associated with their clinical benefit (7;8), broader uptake of eHTA by pharmaceutical innovators offers a route to improving the value delivered by our collective investments in drug research and development (R&D). As we argue in this commentary, the WG’s report provides a coherent framework within which to further define appropriate eHTA methods for specific use cases as well as eHTA’s relationship to other decision-making tools currently used by health technology innovators and funders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalDelphi TechniqueConsensusHumansDecision Making

Stichwörter der Autor:innen

adoption riskdrug developmentearly HTAhealth technology innovationresearch funding prioritization

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, https://ror.org/03rmrcq20University of British Columbia, Vancouver, BC, Canada.
  • Centre for Advancing Health Outcomes, https://ror.org/04g6gva85Providence Health Research Institute, Vancouver, BC, Canada.

ORCID-Profile: Nick Dragojlovic

Förderung

  • NanoMedicines Innovation Network

Zitieren

APA

Dragojlovic, N., Harrison, M., & Lynd, L. D. (2025). On the potential value of eHTA: a commentary on “Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique”. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462325100202

Vancouver

Dragojlovic N, Harrison M, Lynd LD. On the potential value of eHTA: a commentary on “Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique”. International Journal of Technology Assessment in Health Care. 2025. doi:10.1017/s0266462325100202

BibTeX
@article{Dragojlovic2025,
  author = {Dragojlovic, Nick and Harrison, Mark and Lynd, Larry David},
  title = {On the potential value of eHTA: a commentary on “Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique”},
  journal = {International Journal of Technology Assessment in Health Care},
  year = {2025},
  doi = {10.1017/s0266462325100202}
}
Kostenlos starten →